Clinical Trial: Assessment of the Efficacy of E. Coli 5C in the Management of Post-Colonoscopy Symptoms

U.S., Nov. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07931365) titled 'Assessment of the Efficacy of E. Coli 5C in the Management of Post-Colonoscopy Symptoms' on Nov. 06.

Brief Summary: This prospective, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of Escherichia coli 5C (Colipral(R)) in adult patients undergoing diagnostic colonoscopy. Participants will be randomized in a 1:1 ratio to receive either Colipral(R) or placebo for 14 days immediately after colonoscopy. The study aims to determine whether Colipral(R) reduces post-colonoscopy gastrointestinal symptoms compared with placebo, using validated symptom and stool assessment tools, patient-repor...